vendredi 27 avril 2018

Onco Actu du 27 avril 2018


2.5 Etiologie - Gènes

Gene mapping: More Monty Python than Monty Python [The Mermaid's Tale]

2.6 Etiologie - Environnement

Some Thoughts on Exposure to the World Trade Center Wreckage and Cancer [JAMA Oncology]

4. Dépistage, diagnostic et pronostic

Home Tests in Mind, Doudna Startup Races Rivals in CRISPR Diagnostics [Xconomy]

Jennifer Doudna's new CRISPR company will tackle disease detection [FierceBiotech]

CRISPR legend Jennifer Doudna helps some recent college grads launch a diagnostics upstart [EndPoints]

4.12 Biopsies liquides

Noninvasive brain tumor biopsy on the horizon [Washington University in St. Louis]

4.2 Dép., diag. & prono. - Génome

Francis Collins, NIH Director, Answers Reddit’s Genomics Questions [NIH]

5.10 Traitements - Essais

Obese Patients Underrepresented in Cancer Clinical Trials [Boston University]

5.12 Immunothérapies

‘Desperation Oncology’: When Patients Are Dying, Some Cancer Doctors Turn to Immunotherapy [NY Times]

5.12.2 Immunothérapies - CAR-T

CAR-T 2.0? A split, universal and programmable system [FierceBiotech]

CAR-T therapy could be available to NHS patients this year [PharmaTimes]

Senti scientific co-founder Wilson Wong designs the SUPRA — a new, high performance model CAR-T [EndPoints]

NHS preparing to offer ‘game-changing’ cancer treatment [The Guardian]

The Million-Dollar Cancer Treatment: Who Will Pay? [Wall Street Journal]

5.12.3 Immunothérapies-combinaisons

UNC researchers identify promising delivery method for immunotherapy combination [UNC]

5.12.5 Immunothérapies - Pharma

Bristol's Case for Opdivo Optimism Has Shaky Foundations [Bloomberg]

5.3 Traitements - FDA, EMA, NICE...

Gottlieb Offers Solutions for High Generic Drug Prices, Real-Time Postmarket Surveillance [RAPS]

The breakthrough therapy designation for promising cancer drugs is good for patients [STAT]

5.4 Traitements - Economie

Quality Cancer Care: Not Just a Matter of Anti-cancer Medicines [ESMO]

5.5.1.1 ASCO (général) - Industriels

Cabozantinib to Be Featured in 15 Presentations at ASCO 2018 Annual Meeting [Exelixis]

6.10 Politiques

Windrush case: UK to give Albert Thompson indefinite right to remain [The Guardian]

6.9 Controverses

Famed cancer biologist allegedly sexually harassed women for decades [Science]